Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Interpace Diag Group (IDXG)

Interpace Diag Group (IDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 3,664
  • Shares Outstanding, K 4,415
  • Annual Sales, $ 46,930 K
  • Annual Income, $ 6,700 K
  • EBIT $ 9 M
  • EBITDA $ 10 M
  • 60-Month Beta 0.69
  • Price/Sales 0.08
  • Price/Cash Flow 0.46
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.79
  • Most Recent Earnings $0.31 on 11/04/24
  • Next Earnings Date 05/15/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Services

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4433 +87.23%
on 04/25/25
1.1700 -29.06%
on 04/15/25
-0.3275 (-28.29%)
since 04/14/25
3-Month
0.4433 +87.23%
on 04/25/25
1.5100 -45.03%
on 02/25/25
-0.4100 (-33.06%)
since 02/14/25
52-Week
0.4433 +87.23%
on 04/25/25
3.5400 -76.55%
on 11/07/24
-0.6200 (-42.76%)
since 05/14/24

Most Recent Stories

More News
Interpace Biosciences Announces First Quarter 2025 Financial and Business Results

IDXG : 0.8300 (+2.47%)
Effective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk

IDXG : 0.8300 (+2.47%)
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results

IDXG : 0.8300 (+2.47%)
PancraGEN® Will Continue to be Offered While Interpace Re-evaluates its Previously Announced Re-structuring Plan

IDXG : 0.8300 (+2.47%)
Effective 02/07/2025, Interpace Diagnostics® to No Longer Offer PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk

IDXG : 0.8300 (+2.47%)
Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results

IDXG : 0.8300 (+2.47%)
Interpace Biosciences Announces Capital Restructuring of Its Preferred Stock as a First Step Toward Seeking an Uplisting of Its Common Stock to Nasdaq

IDXG : 0.8300 (+2.47%)
Interpace Biosciences Announces First Quarter 2022 Financial and Business Results

 ●Q1 Revenue of $10.4 million up 6% versus Prior Year ●Q1 Net Loss improved $2 million versus Prior Year ●Days Sales Outstanding (DSO) decreased by 27% ...

IDXG : 0.8300 (+2.47%)
Interpace Biosciences Announces Full Year and Fourth Quarter 2021 Financial and Business Results

 ●2021 Full Year Net Revenue of $41.3 Million up 28% vs Prior Year; Fourth Quarter Net Revenue of $10.9 Million up 13% vs Prior Year  ●2021 Full Year Net...

IDXG : 0.8300 (+2.47%)
Interpace Biosciences Terminates Rights Offering Announces Change in CMS Medicare Reimbursement of its Thyroid Tests

PARSIPPANY, NJ, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”) a leader in enabling...

IDXG : 0.8300 (+2.47%)

Business Summary

Interpace Biosciences Inc. is enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services include molecular diagnostic tests, bioinformatics, and pathology services....

See More

Key Turning Points

3rd Resistance Point 0.8928
2nd Resistance Point 0.8803
1st Resistance Point 0.8551
Last Price 0.8300
1st Support Level 0.8174
2nd Support Level 0.8049
3rd Support Level 0.7797

See More

52-Week High 3.5400
Fibonacci 61.8% 2.3571
Fibonacci 50% 1.9916
Fibonacci 38.2% 1.6262
Last Price 0.8300
52-Week Low 0.4433

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar